STAGE III LIVER CANCER
Clinical trials for STAGE III LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III LIVER CANCER trials appear
Sign up with your email to follow new studies for STAGE III LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail shows promise for tough liver cancer
Disease control OngoingThis study tests if adding two immunotherapy drugs (atezolizumab and bevacizumab) to standard chemotherapy works better than chemo plus one immunotherapy for advanced liver cancer that can't be removed surgically. About 88 adults with a specific type of liver cancer will take par…
Matched conditions: STAGE III LIVER CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
New drug combo aims to boost Radiation's punch against tough GI cancers
Symptom relief OngoingThis early-phase study tested an oral drug called ropidoxuridine (IPdR) in 19 people with advanced gastrointestinal cancers that could not be cured. The goal was to find the safest dose and see if the drug could make tumor cells more sensitive to radiation therapy. The study focu…
Matched conditions: STAGE III LIVER CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated May 17, 2026 05:34 UTC